TY - JOUR
T1 - Predictors of late asthmatic response
T2 - Logistic regression and classification tree analyses
AU - Avila, Pedro C.
AU - Segal, Mark R.
AU - Wonc, Hofer H.
AU - Boushey, Homer A.
AU - Fahy, John V.
PY - 2000
Y1 - 2000
N2 - To identify predictors of the late asthmatic response (LAR), we reviewed data from 60 asthmatic subjects who had undergone allergen challenge over the past 5 yr (33 females, age 31.4 ± 6.7 yr [mean ± SD], FEV1 90% ± 14% predicted). Variables considered likely predictors of LAR included baseline FEV1, PC20 methacholine (PC20), sputum eosinophil percent, and the decrease in FEV1 within 20 min of allergen challenge. A LAR (FEV1 ≥ 15% fall between 3 and 7 h after challenge) was documented in 57% of subjects. A variety of logistic regression methods revealed a significant inverse association between LAR and PC20 (odds ratio [OR] = 0.14 [95% CI = 0.03- 0.66]) and a positive association between LAR and the decrease in FEV1 at 20 min (OR = 1.18 [1.04-1.33]). Classification tree analysis revealed that a threshold of 0.25 mg/ml for PC20 was most predictive of LAR; LAR developed in 87% of those with PC20 ≤ 0.25 mg/ml (n = 23) and in 38% of those with PC20 > 0.25 mg/ml (n = 37). Notably, in subjects with PC20 > 0.25 mg/ml, the incidence of LAR increased from 38% to 57% if the allergen-induced decline in FEV1 at 20 min was ≥ 27%. Surprisingly, baseline FEV1 and percent eosinophils in induced sputum were not significantly associated with LAR. We conclude that a threshold value of 0.25 mg/ml for PC20 methacholine is a good predictor of LAR. Measuring the PC20 methacholine may be useful as a screening method to improve the efficiency of identifying asthmatic subjects with a LAR.
AB - To identify predictors of the late asthmatic response (LAR), we reviewed data from 60 asthmatic subjects who had undergone allergen challenge over the past 5 yr (33 females, age 31.4 ± 6.7 yr [mean ± SD], FEV1 90% ± 14% predicted). Variables considered likely predictors of LAR included baseline FEV1, PC20 methacholine (PC20), sputum eosinophil percent, and the decrease in FEV1 within 20 min of allergen challenge. A LAR (FEV1 ≥ 15% fall between 3 and 7 h after challenge) was documented in 57% of subjects. A variety of logistic regression methods revealed a significant inverse association between LAR and PC20 (odds ratio [OR] = 0.14 [95% CI = 0.03- 0.66]) and a positive association between LAR and the decrease in FEV1 at 20 min (OR = 1.18 [1.04-1.33]). Classification tree analysis revealed that a threshold of 0.25 mg/ml for PC20 was most predictive of LAR; LAR developed in 87% of those with PC20 ≤ 0.25 mg/ml (n = 23) and in 38% of those with PC20 > 0.25 mg/ml (n = 37). Notably, in subjects with PC20 > 0.25 mg/ml, the incidence of LAR increased from 38% to 57% if the allergen-induced decline in FEV1 at 20 min was ≥ 27%. Surprisingly, baseline FEV1 and percent eosinophils in induced sputum were not significantly associated with LAR. We conclude that a threshold value of 0.25 mg/ml for PC20 methacholine is a good predictor of LAR. Measuring the PC20 methacholine may be useful as a screening method to improve the efficiency of identifying asthmatic subjects with a LAR.
UR - http://www.scopus.com/inward/record.url?scp=0034086549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034086549&partnerID=8YFLogxK
U2 - 10.1164/ajrccm.161.6.9909056
DO - 10.1164/ajrccm.161.6.9909056
M3 - Article
C2 - 10852792
AN - SCOPUS:0034086549
SN - 1073-449X
VL - 161
SP - 2092
EP - 2095
JO - American journal of respiratory and critical care medicine
JF - American journal of respiratory and critical care medicine
IS - 6
ER -